Vascular changes in the diabetic kidney: Effects of ACE inhibition

Journal of Diabetes and Its Complications

Volumn 9, Issue 4, 1995, Pages 296-300

  Vranes, Dimitria ^a   Dilley, Rodney J ^b   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MEDIA; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; KIDNEY BLOOD VESSEL; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; COMPARATIVE STUDY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPERTROPHY; INDOLES; MALE; MICROCIRCULATION; ORGAN WEIGHT; PEPTIDYL-DIPEPTIDASE A; PERINDOPRIL; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RENAL CIRCULATION; SUPPORT, NON-U.S. GOV'T; SYSTOLE;

EID: 0028823750     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(95)80026-B     Document Type: Article

References (29)

1. Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis, and prevention
2. Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitus
3. Diabetes associated mesenteric vascular hypertrophy is attenuated by angiotensin converting enzyme inhibition
4. Perindopril attenuates diabetes associated vascular hypertrophy [Abstract]
5. Validation in awake rats of a tail-cuff method for measuring systolic pressure
6. Enzymatic determination of glucose and fructose simultaneously
7. A review of plasma renin measurements and their clinical significance
8. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis
9. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
10. Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations
11. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis
12. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
13. Nephropathy in a model combining genetic hypertension with experimental diabetes: Enalapril versus hydralazine and metoprolol therapy
14. Development of glomerular lesions in experimental long-term diabetes in the rat
15. Glomerular filtration rate in the streptozocin diabetic rat: The role of exchangeable sodium, vasoactive hormones and insulin therapy
16. Evidence for direct local effect of angiotensin in vascular hypertrophy In vivo gene transfer of angiotensin converting enzyme
17. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells
18. Bradykinin/nitric oxide is involved in the antihypertensive effects of ACE inhibitors (ACEI) on the mesenteric microvessels of the diabetic rat
19. Acute renal hemodynamic effects of angiotensin converting enzyme inhibitors in diabetic hyperfiltration: The role of kinins
20. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation
21. Albumin permeation of new vessels is increased in diabetic rats
22. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material
23. The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus
24. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat
25. Role of endothelium-derived nitric oxide in the pathogenesis of renal hemodynamic changes of experimental diabetes
26. Endothelium-dependent relaxations are augmented in rats chronically treated with the angiotensin-converting enzyme inhibitor enalapril
27. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries
28. Comparison of blood vessel wall dimensions in normotensive and hypertensive rats by histometric and morphometric methods